Perampanel + Perampanel

Phase 2Completed

0 views this week 0 watching💤 Quiet

Interest: 35/100

Hype Score

Development Stage

✓

Pre-clinical

✓

Phase 1

Phase 2

Phase 3

Approved

Indication / Disease

Epilepsy

Conditions

Epilepsy, Seizures

Trial Timeline

Nov 27, 2018 → Dec 10, 2019

NCT ID

NCT03754582

About Perampanel + Perampanel

Perampanel + Perampanel is a phase 2 stage product being developed by Eisai for Epilepsy. The current trial status is completed. This product is registered under clinical trial identifier NCT03754582. Target conditions include Epilepsy, Seizures.

What happened to similar drugs?

20 of 20 similar drugs in Epilepsy were approved

Approved (20) Terminated (6) Active (0)

✅ZonegranEisaiApproved

✅Perampanel + PlaceboEisaiApproved

✅perampanelEisaiApproved

✅Perampanel Oral TabletEisaiApproved

✅PerampanelEisaiApproved

✅zonisamide low dose group + zonisamide high dose groupEisaiApproved

✅Zonisamide at targeted daily doses of 100-500 mg/day + Placebo administered to match targeted daily doses of 100-500 mg/dayEisaiApproved

Hype Score Breakdown

Clinical

Activity

Company

Novelty

Community

Clinical Trials (8)

NCT ID	Phase	Status	Start	Completion	Indication
NCT04202159	Pre-clinical	Completed	Jan 21, 2020	Mar 31, 2023	Seizures
NCT03754582	Phase 2	Completed	Nov 27, 2018	Dec 10, 2019	Epilepsy
NCT03399734	Phase 1	Completed	Dec 18, 2017	Mar 9, 2018	Healthy Participants
NCT03376997	Phase 1	Completed	Nov 8, 2017	Feb 16, 2018	Healthy Participants
NCT02020486	Phase 1	Completed	Dec 1, 2013	Mar 1, 2014	Healthy
NCT01396577	Phase 1	Completed	Dec 1, 2010	Apr 1, 2011	Healthy
NCT01396590	Phase 1	Completed	Dec 1, 2010	Mar 1, 2011	Healthy
NCT01240187	Phase 1	Completed	Jun 1, 2010	Sep 1, 2010	Partial Onset Epilepsy

Competing Products

20 competing products in Epilepsy

See all competitors

Product	Company	Stage	Hype Score
perampanel	Eisai	Phase 2	35
Lacosamide	UCB	Phase 3	40
Zonisamide + Placebo	Eisai	Phase 3	32
Zonegran	Eisai	Approved	35
perampanel + perampanel	Eisai	Phase 1	29
Perampanel + Placebo	Eisai	Approved	35
perampanel	Eisai	Approved	35
E2007 + Placebo	Eisai	Phase 2	35
Placebo + Rufinamide	Eisai	Phase 3	40
E2007 (perampanel) + Placebo	Eisai	Phase 2	35
Perampanel Oral Tablet	Eisai	Approved	43
perampanel	Eisai	Phase 3	40
Perampanel	Eisai	Pre-clinical	26
Zonisamide + Carbamazepine	Eisai	Phase 3	40
Perampanel	Eisai	Approved	43
Perampanel and Microgynon-30 + Perampanel and Microgynon-30	Eisai	Phase 1	29
Perampanel	Eisai	Phase 2	35
Zonisamide + Placebo	Eisai	Phase 3	40
zonisamide low dose group + zonisamide high dose group	Eisai	Approved	43
E2007 + E2007 + Placebo	Eisai	Phase 2	35